MedPath

Investigating the impact of treating adverse memories on individuals with depression and anxiety

Not Applicable
Completed
Conditions
Depression
Anxiety
Mental Health - Depression
Mental Health - Anxiety
Registration Number
ACTRN12617000693325
Lead Sponsor
Murdoch Universtiy
Brief Summary

For participants with a major depressive episode, the addition of trauma-focused sessions significantly increased the likelihood of remission when compared to TAU, or additional assertiveness training. While no significant treatment difference was noted in depressive symptom change post-treatment, six weeks after treatment those who received an adjunct treatment were more likely to maintain treatment gains than those who received TAU. Furthermore, at 12-week follow-up, participants who received a TFT reported significantly fewer depressive symptoms than those who received assertiveness training

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
49
Inclusion Criteria

Participation in the Hollywood Clinic Mood and Anxiety Management Program.

Exclusion Criteria

Patients who have been assessed to be at a high risk of suicide.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnosis of mood and/or anxiety disorder as measured by the SCID 5.[The SCID 5 was administered pre intervention and 6 weeks after intervention completion only];Depression Anxiety Stress Scale [1-4 weeks pre intervention <br>1-3 weeks post intervention completion<br>6 weeks post intervention completion<br>12 weeks post intervention completion]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath